Job Description:

This is a rare moment to join a program at the inflection point between discovery and the clinic.

AtBeOne'sCell Therapy Research Centerin Taiwan,we'reworking on one of the most innovative pipelines in the company. Our lead allogeneic candidate is advancing toward the clinic—a highly engineered program with the potential to become a first-in-class allogeneic cell therapy.

We usecutting-edgeinduced pluripotent stem cell (iPSC) technology to solve a persistent challenge in the field,making cell therapy scalable and off-the-shelf, rather than constrained by autologous approaches. Through advanced gene editing and cell engineering,we'reworking toward universal cell therapies that aim to be more accessible, efficient, and impactful for patients worldwide.

Today, our Cell Therapy Research Center brings together a team of more than 60 leading scientists, forming one of the largest and most advanced allogeneic cell therapy resear...